NRC Health Reports Q1 Net Income Down 44% Amid Higher Compensation Costs, Announces $60M Share Repurchase

summarizeSummary

NRC Health reported a significant 44% decline in Q1 net income and EPS, primarily due to increased executive compensation, despite modest revenue growth. The company also authorized a new $60 million share repurchase program.

check_boxKey Events

• Q1 Net Income & EPS Decline

  Net income decreased 44% to $3.222 million, and basic EPS fell 44% to $0.14, compared to the prior year, primarily due to increased operating expenses.

• Revenue Growth

  Revenue increased by 3.7% to $34.803 million, marking continued growth in subscription-based services.

• Increased Operating Expenses

  Selling, general, and administrative expenses rose 30% to $13.419 million, primarily due to $1.4 million higher stock-based compensation and $0.5 million in executive salary expense.

• Strong TRCV Growth

  Total Recurring Contract Value (TRCV) grew 13.2% to $152.070 million, indicating positive future revenue trends.

auto_awesomeAnalysis

NRC Health's first-quarter results, previously announced in an 8-K on April 28, 2026, show a substantial decrease in profitability, with net income and EPS falling by 44% year-over-year. This decline was largely driven by a 30% increase in selling, general, and administrative expenses, which included higher stock-based compensation and executive salaries. While revenue saw modest growth and Total Recurring Contract Value (TRCV) increased by 13.2%, indicating future revenue potential, the immediate impact on earnings is a concern. The company also detailed a new $60 million share repurchase program, representing a significant commitment to returning capital to shareholders, which provides a positive counter-signal to the earnings weakness. The subsequent event regarding executive equity awards and tax bonuses, also previously disclosed in an 8-K and 10-K/A on April 28, 2026, is expected to result in a $9.4 million expense in Q2 2026. Investors should monitor the impact of these compensation changes on future profitability and the execution of the share repurchase program.